
22 Jul 2026
by: khater
Compelling Investment Opportunity
The stock is currently transitioning from a long-term bearish trend into a Major Accumulation Phase. Following the significant decline from 2021 peaks, the price has found a solid floor. The current "flat" price action is a classic indicator that selling pressure has been exhausted, and "Smart Money" is likely building positions at these historic lows. 2. Key Technical Levels Current Entry Zone: 0.342 EGP The Breakout Pivot: 0.420 EGP. A decisive close above this level with high trading volume will confirm the end of the sideways trend and the start of the bullish reversal. Strategic Support (Stop Loss): As indicated on the chart, 0.088 EGP serves as the ultimate safety net, though 0.300 EGP acts as the immediate psychological support. 3. Investment Targets This setup offers a highly attractive Risk/Reward Ratio: Primary Target: 0.956 EGP Potential Return: Approximately +180% from current levels. Investment Horizon: This is a medium-to-long-term play, targeting the recovery of previous price gaps and historical resistance levels. 4. Technical Summary The Setup: This is a textbook "Bottom Fishing" opportunity. The stock is fundamentally undervalued at this price point. The Momentum: On larger timeframes (Weekly/Monthly), the stock is in deep "Oversold" territory, suggesting that the downside is limited while the upside potential is explosive. Executive Summary (Simplified) Speed Medical is currently a "Diamond in the Rough." By entering at 0.342, you are buying near the historical bottom. While this type of play requires patience, the objective of 0.956 is technically sound as the stock seeks to return to its fair market value. Strategy: Accumulate at current levels, set your sights on 0.95, and exercise patience as the market cycle shifts from accumulation to markup.
Speed Medical Stock Achieves 18.42% of Its Target
22 Jul 2026
by: khater
The stock has successfully transitioned out of its horizontal accumulation phase, cleanly piercing the first milestone at 0.42 and establishing acceptance at 0.454. This price action confirms the completion of the base-building structure and the initiation of directional expansion, achieving an exact completion rate of 18.42% toward the broader 0.950 objective while fully preserving the risk-management parameters and structural stop-loss.